Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial.

Publikation

Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial.

Wissenschaftlicher Artikel/Review - 25.03.2024

Muellhaupt Gautier, Hechelhammer Lukas, Graf Nicole, Mordasini Livio, Schmid Hans-Peter, Engeler Daniel, Abt Dominik

Zitation

Muellhaupt G, Hechelhammer L, Graf N, Mordasini L, Schmid H, Engeler D, Abt D. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial. Eur Urol Focus 2024; 10:788-795.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Eur Urol Focus 2024; 10

Veröffentlichungsdatum

25.03.2024

eISSN (Online)

2405-4569

Seiten

788-795

Kurzbeschreibung/Zielsetzung

Prostatic artery embolisation (PAE) and transurethral resection of the prostate (TURP) are two of the surgical options for treatment of lower urinary tract symptoms/benign prostatic obstruction (LUTS/BPO). Our aim was to compare the efficacy and safety of PAE and TURP for LUTS/BPO treatment at long-term follow-up.